Fatal Complication of Stem Cell Transplants Gets Its First FDA-Approved Therapy
Omeros’s complement system drug Yartemlea is now FDA approved for treating a severe and potentially…
Fatal Complication of Stem Cell Transplants Gets Its First FDA-Approved Therapy
Omeros’s complement system drug Yartemlea is now FDA approved for treating a severe and potentially fatal complication of hematopoietic stem cell transplants. Our recap of other regulatory actions includes drug approvals in cancer, rare disease, and metabolic disorders. The post Fatal Complication of Stem Cell Transplants Gets Its First FDA-Approved Therapy appeared first on MedCity…
Hospital-at-Home Bodes Well for Rural Patients, Research Shows
New research from Mass General Brigham demonstrates that hospital-at-home care can safely deliver comparable outcomes for rural patients — with significant cost savings when patients are transferred home early in their hospital stay. The post Hospital-at-Home Bodes Well for Rural Patients, Research Shows appeared first on MedCity News.
A Massive Wave of Eye Disease is Coming, and Healthcare is Unprepared
The cruel irony is that incredibly effective treatments already exist. Many people, however, cannot access them due to barriers to care The post A Massive Wave of Eye Disease is Coming, and Healthcare is Unprepared appeared first on MedCity News.
Why Metabolic Health Should Be Every Employer’s Next Benefits Priority
Despite its impact, metabolic health rarely appears on the HR dashboard. That oversight is costing employers more than they realize. The post Why Metabolic Health Should Be Every Employer’s Next Benefits Priority appeared first on MedCity News.
Scaling Healthcare Starts at Home: The Case for Self-Treatment
By empowering patients to take part in their own care, we can expand capacity, improve outcomes, and make the system more sustainable. The post Scaling Healthcare Starts at Home: The Case for Self-Treatment appeared first on MedCity News.
What If Training the Brain, Not Medicating the Body, Is the Future of Medicine?
The technology already exists that would allow us to close the loop between physiological dysfunction and neural adaptation in real time. The question is not if, but how, rapidly this capability will reshape therapeutic paradigms and the economics that sustain them. The post What If Training the Brain, Not Medicating the Body, Is the Future…
What Is HHS Proposing in Its New Rule?
HHS proposed changes that would roll back many Biden-era policies, eliminate most health tech certification criteria,and scrap planned transparency requirements for healthcare AI tools. The agency argues the move will reduce regulatory burden and save developers time and money. The post What Is HHS Proposing in Its New Rule? appeared first on MedCity News.
Sanofi’s Vaccine Lineup Gets a Shot in the Arm With $2.2B Dynavax Acquisition
Dynavax Technologies brings Sanofi a commercialized hepatitis B vaccine and a clinical-stage shingles vaccine, both of which offer differentiation from products marketed by GSK. It’s Sanofi’s second billion-dollar vaccines acquisition of 2025. The post Sanofi’s Vaccine Lineup Gets a Shot in the Arm With $2.2B Dynavax Acquisition appeared first on MedCity News.
Morgan Health: 5 Predictions for Employer-Sponsored Insurance in 2026
Affordability, drug costs and AI will be top of mind for employers in 2026, according to Morgan Health CEO Dan Mendelson. The post Morgan Health: 5 Predictions for Employer-Sponsored Insurance in 2026 appeared first on MedCity News.
Knowledge Is Power: How Early Detection Can Transform Alzheimer’s Care
New tools and evidence can empower early action against Alzheimer’s before symptoms strike The post Knowledge Is Power: How Early Detection Can Transform Alzheimer’s Care appeared first on MedCity News.
